Clin2
NCT07082933Possibly a fitNot yet recruiting

Long-term survival in pulmonary hypertension with diabetes

Pulmonary Arterial Hypertension (PAH)

Treatments studied

Part of Hormones & metabolism, Lungs & breathing clinical trials.

This study looks at how long people with pulmonary hypertension (high blood pressure in the lungs) and diabetes live, and what factors might affect their survival. If you have both conditions, joining this study could help doctors better understand your prognosis and improve care for others like you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
5,000 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You must be between 18 and 80 years old.
  • You must have a diagnosis of pulmonary hypertension (high blood pressure in the lungs) from a doctor.
  • You must not have any type of cancer.
  • You must be able to make your own medical decisions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07852403Recruiting
Sleep problems and outcomes in pulmonary arterial hypertension

This study looks at how sleep-disordered breathing (abnormal breathing during sleep) affects the long-term health of people with pulmonary arterial hypertension (PAH), a type of high blood pressure in the lungs. By participating, you will have a sleep study and be followed over time to see how your breathing during sleep relates to your PAH outcomes.

Beijing
NCT05958901Recruiting
Study of pulmonary hypertension in everyday clinical care

This observational study is looking at people diagnosed with pulmonary hypertension to better understand how it behaves over time. You may help researchers by allowing repeated check-ins for years and sharing symptom and test information.

Guangzhou, Guangdong
NCT04654650Recruiting
Study of adults with pulmonary hypertension for long-term data

This study follows adults with pulmonary hypertension over the long term and collects information (and possibly samples) to better understand how the condition changes over time. It may help researchers learn what factors affect outcomes, which can improve care in the future.

Hamburg, Free and Hanseatic City of Hamburg
NCT05368467Recruiting
Registry study for pulmonary hypertension patients

This is a long-term study that enrolls people who have been diagnosed with pulmonary hypertension (high blood pressure in the lung arteries). It collects medical information over time to better understand the condition and what to expect.

Guangzhou, Guangdong
NCT01730092Recruiting
Study of blood and imaging biomarkers in pulmonary artery hypertension

This study tracks natural changes in “biomarkers” (measurable signals in blood) and imaging findings in people with pulmonary arterial hypertension (PAH) or suspected PAH. It also includes healthy people for comparison, helping researchers understand what these signals mean over time.

Bethesda, Maryland
NCT07131241Recruiting
A study to predict risk in pulmonary hypertension

This study aims to better predict the future risk for people with pulmonary hypertension (high blood pressure in the lungs) by combining different types of health information collected over time. If you join, researchers will track your health data to build a tool that personalizes care and improves outcomes.

Fuzhou, Fujian

Hear when a new Pulmonary Arterial Hypertension (PAH) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.